Tuberculosis Therapeutics market worldwide is projected to grow by US$376. 1 Million, driven by a compounded growth of 4. 9%. Active TB, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tuberculosis Therapeutics Industry" - https://www.reportlinker.com/p05818022/?utm_source=GNW
3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$810.1 Million by the year 2025, Active TB will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 3.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$13.2 Million to the region’s size and clout in the next 5 to 6 years. Over US$10.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Active TB will reach a market size of US$43.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.9% over the next couple of years and add approximately US$110.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, AstraZeneca PLC; Eli Lilly and Company; GlaxoSmithKline PLC; Johnson & Johnson; Lupin Ltd.; Merck & Co., Inc.; Otsuka Pharmaceutical Co., Ltd.; Panacea Biotec Ltd.; Pfizer, Inc.


Read the full report: https://www.reportlinker.com/p05818022/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Tuberculosis Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Tuberculosis Therapeutics Global Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 2: Tuberculosis Therapeutics Global Retrospective Market
Scenario in US$ Thousand by Region/Country: 2009-2017
Table 3: Tuberculosis Therapeutics Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Active TB (Disease Type) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 5: Active TB (Disease Type) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 6: Active TB (Disease Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Latent TB (Disease Type) Potential Growth Markets
Worldwide in US$ Thousand: 2018 to 2025
Table 8: Latent TB (Disease Type) Historic Market Perspective
by Region/Country in US$ Thousand: 2009 to 2017
Table 9: Latent TB (Disease Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: First-Line Therapy (Therapy) Geographic Market Spread
Worldwide in US$ Thousand: 2018 to 2025
Table 11: First-Line Therapy (Therapy) Region Wise Breakdown of
Global Historic Demand in US$ Thousand: 2009 to 2017
Table 12: First-Line Therapy (Therapy) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Second-Line Therapy (Therapy) World Market Estimates
and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
Table 14: Second-Line Therapy (Therapy) Market Historic Review
by Region/Country in US$ Thousand: 2009 to 2017
Table 15: Second-Line Therapy (Therapy) Market Share Breakdown
by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Tuberculosis Therapeutics Market Share (in %) by Company:
2019 & 2025
Table 16: United States Tuberculosis Therapeutics Market
Estimates and Projections in US$ Thousand by Disease Type: 2018
to 2025
Table 17: Tuberculosis Therapeutics Market in the United States
by Disease Type: A Historic Review in US$ Thousand for
2009-2017
Table 18: United States Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 19: United States Tuberculosis Therapeutics Market
Estimates and Projections in US$ Thousand by Therapy: 2018 to
2025
Table 20: Tuberculosis Therapeutics Market in the United States
by Therapy: A Historic Review in US$ Thousand for 2009-2017
Table 21: United States Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
CANADA
Table 22: Canadian Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
Table 23: Canadian Tuberculosis Therapeutics Historic Market
Review by Disease Type in US$ Thousand: 2009-2017
Table 24: Tuberculosis Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
Table 25: Canadian Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018 to 2025
Table 26: Canadian Tuberculosis Therapeutics Historic Market
Review by Therapy in US$ Thousand: 2009-2017
Table 27: Tuberculosis Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
JAPAN
Table 28: Japanese Market for Tuberculosis Therapeutics: Annual
Sales Estimates and Projections in US$ Thousand by Disease Type
for the Period 2018-2025
Table 29: Tuberculosis Therapeutics Market in Japan: Historic
Sales Analysis in US$ Thousand by Disease Type for the Period
2009-2017
Table 30: Japanese Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 31: Japanese Market for Tuberculosis Therapeutics: Annual
Sales Estimates and Projections in US$ Thousand by Therapy for
the Period 2018-2025
Table 32: Tuberculosis Therapeutics Market in Japan: Historic
Sales Analysis in US$ Thousand by Therapy for the Period
2009-2017
Table 33: Japanese Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
CHINA
Table 34: Chinese Tuberculosis Therapeutics Market Growth
Prospects in US$ Thousand by Disease Type for the Period
2018-2025
Table 35: Tuberculosis Therapeutics Historic Market Analysis in
China in US$ Thousand by Disease Type: 2009-2017
Table 36: Chinese Tuberculosis Therapeutics Market by Disease
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 37: Chinese Tuberculosis Therapeutics Market Growth
Prospects in US$ Thousand by Therapy for the Period 2018-2025
Table 38: Tuberculosis Therapeutics Historic Market Analysis in
China in US$ Thousand by Therapy: 2009-2017
Table 39: Chinese Tuberculosis Therapeutics Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Tuberculosis Therapeutics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 40: European Tuberculosis Therapeutics Market Demand
Scenario in US$ Thousand by Region/Country: 2018-2025
Table 41: Tuberculosis Therapeutics Market in Europe: A
Historic Market Perspective in US$ Thousand by Region/Country
for the Period 2009-2017
Table 42: European Tuberculosis Therapeutics Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 43: European Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018-2025
Table 44: Tuberculosis Therapeutics Market in Europe in US$
Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 45: European Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 46: European Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018-2025
Table 47: Tuberculosis Therapeutics Market in Europe in US$
Thousand by Therapy: A Historic Review for the Period 2009-2017
Table 48: European Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
FRANCE
Table 49: Tuberculosis Therapeutics Market in France by Disease
Type: Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 50: French Tuberculosis Therapeutics Historic Market
Scenario in US$ Thousand by Disease Type: 2009-2017
Table 51: French Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 52: Tuberculosis Therapeutics Market in France by
Therapy: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 53: French Tuberculosis Therapeutics Historic Market
Scenario in US$ Thousand by Therapy: 2009-2017
Table 54: French Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
GERMANY
Table 55: Tuberculosis Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Disease
Type for the Period 2018-2025
Table 56: German Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Disease Type: 2009-2017
Table 57: German Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 58: Tuberculosis Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Therapy
for the Period 2018-2025
Table 59: German Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Therapy: 2009-2017
Table 60: German Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
ITALY
Table 61: Italian Tuberculosis Therapeutics Market Growth
Prospects in US$ Thousand by Disease Type for the Period
2018-2025
Table 62: Tuberculosis Therapeutics Historic Market Analysis in
Italy in US$ Thousand by Disease Type: 2009-2017
Table 63: Italian Tuberculosis Therapeutics Market by Disease
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 64: Italian Tuberculosis Therapeutics Market Growth
Prospects in US$ Thousand by Therapy for the Period 2018-2025
Table 65: Tuberculosis Therapeutics Historic Market Analysis in
Italy in US$ Thousand by Therapy: 2009-2017
Table 66: Italian Tuberculosis Therapeutics Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 67: United Kingdom Market for Tuberculosis Therapeutics:
Annual Sales Estimates and Projections in US$ Thousand by
Disease Type for the Period 2018-2025
Table 68: Tuberculosis Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Disease
Type for the Period 2009-2017
Table 69: United Kingdom Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 70: United Kingdom Market for Tuberculosis Therapeutics:
Annual Sales Estimates and Projections in US$ Thousand by
Therapy for the Period 2018-2025
Table 71: Tuberculosis Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Therapy for
the Period 2009-2017
Table 72: United Kingdom Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
SPAIN
Table 73: Spanish Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
Table 74: Spanish Tuberculosis Therapeutics Historic Market
Review by Disease Type in US$ Thousand: 2009-2017
Table 75: Tuberculosis Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Disease Type for 2009, 2019, and
2025
Table 76: Spanish Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018 to 2025
Table 77: Spanish Tuberculosis Therapeutics Historic Market
Review by Therapy in US$ Thousand: 2009-2017
Table 78: Tuberculosis Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
RUSSIA
Table 79: Russian Tuberculosis Therapeutics Market Estimates
and Projections in US$ Thousand by Disease Type: 2018 to 2025
Table 80: Tuberculosis Therapeutics Market in Russia by Disease
Type: A Historic Review in US$ Thousand for 2009-2017
Table 81: Russian Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 82: Russian Tuberculosis Therapeutics Market Estimates
and Projections in US$ Thousand by Therapy: 2018 to 2025
Table 83: Tuberculosis Therapeutics Market in Russia by
Therapy: A Historic Review in US$ Thousand for 2009-2017
Table 84: Russian Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 85: Rest of Europe Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Disease Type:
2018-2025
Table 86: Tuberculosis Therapeutics Market in Rest of Europe in
US$ Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 87: Rest of Europe Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 88: Rest of Europe Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025
Table 89: Tuberculosis Therapeutics Market in Rest of Europe in
US$ Thousand by Therapy: A Historic Review for the Period
2009-2017
Table 90: Rest of Europe Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 91: Asia-Pacific Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Region/Country:
2018-2025
Table 92: Tuberculosis Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Thousand by Region/Country for
the Period 2009-2017
Table 93: Asia-Pacific Tuberculosis Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 94: Tuberculosis Therapeutics Market in Asia-Pacific by
Disease Type: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 95: Asia-Pacific Tuberculosis Therapeutics Historic
Market Scenario in US$ Thousand by Disease Type: 2009-2017
Table 96: Asia-Pacific Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 97: Tuberculosis Therapeutics Market in Asia-Pacific by
Therapy: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 98: Asia-Pacific Tuberculosis Therapeutics Historic
Market Scenario in US$ Thousand by Therapy: 2009-2017
Table 99: Asia-Pacific Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
AUSTRALIA
Table 100: Tuberculosis Therapeutics Market in Australia:
Recent Past, Current and Future Analysis in US$ Thousand by
Disease Type for the Period 2018-2025
Table 101: Australian Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Disease Type: 2009-2017
Table 102: Australian Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 103: Tuberculosis Therapeutics Market in Australia:
Recent Past, Current and Future Analysis in US$ Thousand by
Therapy for the Period 2018-2025
Table 104: Australian Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Therapy: 2009-2017
Table 105: Australian Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
INDIA
Table 106: Indian Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
Table 107: Indian Tuberculosis Therapeutics Historic Market
Review by Disease Type in US$ Thousand: 2009-2017
Table 108: Tuberculosis Therapeutics Market in India:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
Table 109: Indian Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018 to 2025
Table 110: Indian Tuberculosis Therapeutics Historic Market
Review by Therapy in US$ Thousand: 2009-2017
Table 111: Tuberculosis Therapeutics Market in India:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
SOUTH KOREA
Table 112: Tuberculosis Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Thousand by
Disease Type for the Period 2018-2025
Table 113: South Korean Tuberculosis Therapeutics Historic
Market Analysis in US$ Thousand by Disease Type: 2009-2017
Table 114: Tuberculosis Therapeutics Market Share Distribution
in South Korea by Disease Type: 2009 VS 2019 VS 2025
Table 115: Tuberculosis Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Thousand by
Therapy for the Period 2018-2025
Table 116: South Korean Tuberculosis Therapeutics Historic
Market Analysis in US$ Thousand by Therapy: 2009-2017
Table 117: Tuberculosis Therapeutics Market Share Distribution
in South Korea by Therapy: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 118: Rest of Asia-Pacific Market for Tuberculosis
Therapeutics: Annual Sales Estimates and Projections in US$
Thousand by Disease Type for the Period 2018-2025
Table 119: Tuberculosis Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Thousand by
Disease Type for the Period 2009-2017
Table 120: Rest of Asia-Pacific Tuberculosis Therapeutics
Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 121: Rest of Asia-Pacific Market for Tuberculosis
Therapeutics: Annual Sales Estimates and Projections in US$
Thousand by Therapy for the Period 2018-2025
Table 122: Tuberculosis Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Thousand by
Therapy for the Period 2009-2017
Table 123: Rest of Asia-Pacific Tuberculosis Therapeutics
Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 124: Latin American Tuberculosis Therapeutics Market
Trends by Region/Country in US$ Thousand: 2018-2025
Table 125: Tuberculosis Therapeutics Market in Latin America in
US$ Thousand by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 126: Latin American Tuberculosis Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 127: Latin American Tuberculosis Therapeutics Market
Growth Prospects in US$ Thousand by Disease Type for the Period
2018-2025
Table 128: Tuberculosis Therapeutics Historic Market Analysis
in Latin America in US$ Thousand by Disease Type: 2009-2017
Table 129: Latin American Tuberculosis Therapeutics Market by
Disease Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
Table 130: Latin American Tuberculosis Therapeutics Market
Growth Prospects in US$ Thousand by Therapy for the Period
2018-2025
Table 131: Tuberculosis Therapeutics Historic Market Analysis
in Latin America in US$ Thousand by Therapy: 2009-2017
Table 132: Latin American Tuberculosis Therapeutics Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 133: Argentinean Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Disease Type:
2018-2025
Table 134: Tuberculosis Therapeutics Market in Argentina in US$
Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 135: Argentinean Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 136: Argentinean Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025
Table 137: Tuberculosis Therapeutics Market in Argentina in US$
Thousand by Therapy: A Historic Review for the Period 2009-2017
Table 138: Argentinean Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
BRAZIL
Table 139: Tuberculosis Therapeutics Market in Brazil by
Disease Type: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 140: Brazilian Tuberculosis Therapeutics Historic Market
Scenario in US$ Thousand by Disease Type: 2009-2017
Table 141: Brazilian Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 142: Tuberculosis Therapeutics Market in Brazil by
Therapy: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 143: Brazilian Tuberculosis Therapeutics Historic Market
Scenario in US$ Thousand by Therapy: 2009-2017
Table 144: Brazilian Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
MEXICO
Table 145: Tuberculosis Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Thousand by Disease
Type for the Period 2018-2025
Table 146: Mexican Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Disease Type: 2009-2017
Table 147: Mexican Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 148: Tuberculosis Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Thousand by Therapy
for the Period 2018-2025
Table 149: Mexican Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Therapy: 2009-2017
Table 150: Mexican Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 151: Rest of Latin America Tuberculosis Therapeutics
Market Estimates and Projections in US$ Thousand by Disease
Type: 2018 to 2025
Table 152: Tuberculosis Therapeutics Market in Rest of Latin
America by Disease Type: A Historic Review in US$ Thousand for
2009-2017
Table 153: Rest of Latin America Tuberculosis Therapeutics
Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 154: Rest of Latin America Tuberculosis Therapeutics
Market Estimates and Projections in US$ Thousand by Therapy:
2018 to 2025
Table 155: Tuberculosis Therapeutics Market in Rest of Latin
America by Therapy: A Historic Review in US$ Thousand for
2009-2017
Table 156: Rest of Latin America Tuberculosis Therapeutics
Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 157: The Middle East Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Region/Country:
2018-2025
Table 158: Tuberculosis Therapeutics Market in the Middle East
by Region/Country in US$ Thousand: 2009-2017
Table 159: The Middle East Tuberculosis Therapeutics Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 160: The Middle East Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Disease Type: 2018
to 2025
Table 161: The Middle East Tuberculosis Therapeutics Historic
Market by Disease Type in US$ Thousand: 2009-2017
Table 162: Tuberculosis Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
Table 163: The Middle East Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Therapy: 2018 to
2025
Table 164: The Middle East Tuberculosis Therapeutics Historic
Market by Therapy in US$ Thousand: 2009-2017
Table 165: Tuberculosis Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
IRAN
Table 166: Iranian Market for Tuberculosis Therapeutics: Annual
Sales Estimates and Projections in US$ Thousand by Disease Type
for the Period 2018-2025
Table 167: Tuberculosis Therapeutics Market in Iran: Historic
Sales Analysis in US$ Thousand by Disease Type for the Period
2009-2017
Table 168: Iranian Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 169: Iranian Market for Tuberculosis Therapeutics: Annual
Sales Estimates and Projections in US$ Thousand by Therapy for
the Period 2018-2025
Table 170: Tuberculosis Therapeutics Market in Iran: Historic
Sales Analysis in US$ Thousand by Therapy for the Period
2009-2017
Table 171: Iranian Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
ISRAEL
Table 172: Israeli Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018-2025
Table 173: Tuberculosis Therapeutics Market in Israel in US$
Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 174: Israeli Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 175: Israeli Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018-2025
Table 176: Tuberculosis Therapeutics Market in Israel in US$
Thousand by Therapy: A Historic Review for the Period 2009-2017
Table 177: Israeli Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 178: Saudi Arabian Tuberculosis Therapeutics Market
Growth Prospects in US$ Thousand by Disease Type for the Period
2018-2025
Table 179: Tuberculosis Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Thousand by Disease Type: 2009-2017
Table 180: Saudi Arabian Tuberculosis Therapeutics Market by
Disease Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
Table 181: Saudi Arabian Tuberculosis Therapeutics Market
Growth Prospects in US$ Thousand by Therapy for the Period
2018-2025
Table 182: Tuberculosis Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Thousand by Therapy: 2009-2017
Table 183: Saudi Arabian Tuberculosis Therapeutics Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 184: Tuberculosis Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Thousand by Disease Type for the Period 2018-2025
Table 185: United Arab Emirates Tuberculosis Therapeutics
Historic Market Analysis in US$ Thousand by Disease Type:
2009-2017
Table 186: Tuberculosis Therapeutics Market Share Distribution
in United Arab Emirates by Disease Type: 2009 VS 2019 VS 2025
Table 187: Tuberculosis Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Thousand by Therapy for the Period 2018-2025
Table 188: United Arab Emirates Tuberculosis Therapeutics
Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
Table 189: Tuberculosis Therapeutics Market Share Distribution
in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 190: Tuberculosis Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Thousand
by Disease Type for the Period 2018-2025
Table 191: Rest of Middle East Tuberculosis Therapeutics
Historic Market Analysis in US$ Thousand by Disease Type:
2009-2017
Table 192: Rest of Middle East Tuberculosis Therapeutics Market
Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 193: Tuberculosis Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Thousand
by Therapy for the Period 2018-2025
Table 194: Rest of Middle East Tuberculosis Therapeutics
Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
Table 195: Rest of Middle East Tuberculosis Therapeutics Market
Share Breakdown by Therapy: 2009 VS 2019 VS 2025
AFRICA
Table 196: African Tuberculosis Therapeutics Market Estimates
and Projections in US$ Thousand by Disease Type: 2018 to 2025
Table 197: Tuberculosis Therapeutics Market in Africa by
Disease Type: A Historic Review in US$ Thousand for 2009-2017
Table 198: African Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 199: African Tuberculosis Therapeutics Market Estimates
and Projections in US$ Thousand by Therapy: 2018 to 2025
Table 200: Tuberculosis Therapeutics Market in Africa by
Therapy: A Historic Review in US$ Thousand for 2009-2017
Table 201: African Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

ASTRAZENECA PLC
ELI LILLY AND COMPANY
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
LUPIN LTD.
MERCK & CO., INC.
OTSUKA PHARMACEUTICAL CO., LTD.
PANACEA BIOTEC LTD.
PFIZER, INC

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818022/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
                  US: (339)-368-6001
                  Intl: +1 339-368-6001